WO2024241162 - PEPTIDE FOR SITE-SPECIFIC ANTIBODY CONJUGATION AND METHOD OF USE
National phase entry is expected:
Publication Number
WO/2024/241162
Publication Date
28.11.2024
International Application No.
PCT/IB2024/054780
International Filing Date
17.05.2024
Title **
[English]
PEPTIDE FOR SITE-SPECIFIC ANTIBODY CONJUGATION AND METHOD OF USE
[French]
PEPTIDE POUR CONJUGAISON D'ANTICORPS SPÉCIFIQUE À UN SITE ET PROCÉDÉ D'UTILISATION
Applicants **
PIXELGEN TECHNOLOGIES AB
Hagaplan 4
113 68 Stockholm, SE
Inventors
FREDRIKSSON, Simon
c/o Pixelgen Technologies AB
Hagaplan 4
113 68 Stockholm, SE
Priority Data
63/469,016
25.05.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1270 | |
| EPO | Filing, Examination | 6957 | |
| Japan | Filing | 531 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 3635 |
Total: 12968 USD
Abstract[English]
Provided herein is a peptide comprising the amino acid sequence DCAYHLGELXWCT (SEQ ID NO: 1), wherein X is para-benzoyl phenylalanine (pBPA) and the peptide is 13-17 amino acids in length. Methods and kits are also provided. The peptide may be used to conjugated other molecules, e.g., drugs and/or oligonucleotides to an antibody[French]
L'invention concerne un peptide comprenant la séquence d'acides aminés DCAYHLGELXW CT (SEQ ID NO : 1), X étant la para-benzoyl phénylalanine (pBPA) et le peptide étant de 13 à 17 acides aminés en longueur. L'invention concerne également des procédés et des kits. Le peptide peut être utilisé pour conjuguer d'autres molécules, par exemple, des médicaments et/ou des oligonucléotides à un anticorps.